Cancer genes and the pathways they control, Nature Medicine, vol.10, issue.8, pp.789-799, 2004. ,
Why do cancers have high aerobic glycolysis?, Nature Reviews Cancer, vol.4, issue.11, pp.891-899, 2004. ,
On the origin of cancer cells, Science, vol.123, issue.3191, pp.309-314, 1956. ,
Brick by brick: metabolism and tumor cell growth, Current Opinion in Genetics and Development, vol.18, issue.1, pp.54-61, 2008. ,
Regulation of metabolism by hypoxiainducible factor 1, Cold Spring Harbor Symposia on Quantitative Biology, vol.76, pp.347-353, 2011. ,
HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia, Cell Metabolism, vol.3, issue.3, pp.177-185, 2006. ,
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance, Cancer Cell, vol.9, issue.6, pp.425-434, 2006. ,
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression, Proceedings of the National Academy of Sciences of the United States of America, vol.107, pp.2037-2042, 2010. ,
Understanding the warburg effect: the metabolic requirements of cell proliferation, Science, vol.324, issue.5930, pp.1029-1033, 2009. ,
The M1-and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing, Journal of Biological Chemistry, vol.261, issue.29, pp.13807-13812, 1986. ,
Pyruvate kinase type M2 and its role in tumor growth and spreading, Seminars in Cancer Biology, vol.15, issue.4, pp.300-308, 2005. ,
C-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism, Nature, vol.458, issue.7239, pp.762-765, 2009. ,
Glutathione in cancer biology and therapy, Critical Reviews in Clinical Laboratory Sciences, vol.43, issue.2, pp.143-181, 2006. ,
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer, Cell Biology and Cancer, vol.29, issue.3, pp.313-324, 2010. ,
Bidirectional transport of amino acids regulates mTOR and autophagy, Cell, vol.136, issue.3, pp.521-534, 2009. ,
Molecular mechanisms contributing to glutamine-mediated intestinal cell survival, American Journal of Physiology-Gastrointestinal and Liver Physiology, vol.293, issue.6, pp.1262-1271, 2007. ,
Ammonia derived from glutaminolysis is a diffusible regulator of autophagy, Science Signaling, vol.3, issue.119, p.31, 2010. ,
Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment, International Journal of Biochemistry and Cell Biology, vol.43, issue.7, pp.1045-1051, 2011. ,
CTGF drives autophagy, glycolysis and senescence in cancerassociated fibroblasts via HIF1 activation, metabolically promoting tumor growth, Cell Cycle, vol.11, issue.12, pp.2272-2284, 2012. ,
Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer, International Journal of Radiation Oncology Biology Physics, vol.51, issue.2, pp.349-353, 2001. ,
High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers, Cancer Research, vol.60, issue.4, pp.916-921, 2000. ,
Inhibitory effect of tumor cell-derived lactic acid on human T cells, Blood, vol.109, issue.9, pp.3812-3819, 2007. ,
Tumor metabolism as modulator of immune response and tumor progression, Seminars in Cancer Biology, vol.22, issue.4, pp.335-341, 2012. ,
Inborn and acquired metabolic defects in cancer, Journal of Molecular Medicine, vol.89, issue.3, pp.213-220, 2011. ,
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer the multiple leiomyoma consortium, Nature Genetics, vol.30, issue.4, pp.406-410, 2002. ,
Mitochondrial tumour suppressors: a genetic and biochemical update, Nature Reviews Cancer, vol.5, issue.11, pp.857-866, 2005. ,
An integrated genomic analysis of human glioblastoma multiforme, Science, vol.321, issue.5897, pp.1807-1812, 2008. ,
IDH1 and IDH2 mutations in gliomas, New England Journal of Medicine, vol.360, issue.8, pp.765-773, 2009. ,
Recurring mutations found by sequencing an acute myeloid leukemia genome, New England Journal of Medicine, vol.361, issue.11, pp.1058-1066, 2009. ,
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate, Nature, vol.462, issue.7274, pp.739-744, 2009. ,
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases, EMBO Reports, vol.12, issue.5, pp.463-469, 2011. ,
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of -ketoglutaratedependent dioxygenases, Cancer Cell, vol.19, issue.1, pp.17-30, 2011. ,
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation, Cancer Cell, vol.18, issue.6, pp.553-567, 2010. ,
IDH mutation impairs histone demethylation and results in a block to cell differentiation, Nature, vol.483, pp.474-478, 2012. ,
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics, Nature, vol.488, pp.656-659, 2012. ,
Reductive carboxylation supports growth in tumour cells with defective mitochondria, Nature, vol.481, pp.385-388, 2012. ,
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia, Nature, vol.481, pp.380-384, 2011. ,
A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo, Nature, vol.199, issue.4888, pp.79-80, 1963. ,
Mouse myeloma tumor stem cells: a primary cell culture assay, Journal of the National Cancer Institute, vol.46, issue.2, pp.411-422, 1971. ,
Primary bioassay of human myeloma stem cells, Journal of Clinical Investigation, vol.60, issue.4, pp.846-854, 1977. ,
Breast cancer stem cells revealed, Proceedings of the National Academy of Sciences of the United States of America, vol.100, pp.3547-3549, 2003. ,
Singlecell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity, Proceedings of the National Academy of Sciences of the United States of America, vol.105, pp.13427-13432, 2008. ,
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature, vol.367, issue.6464, pp.645-648, 1994. ,
Prospective identification of tumorigenic breast cancer cells, Proceedings of the National Academy of Sciences of the United States of America, vol.100, pp.3983-3988, 2003. ,
Identification of human brain tumour initiating cells, Nature, vol.432, issue.7015, pp.396-401, 2004. ,
Radial glia cells are candidate stem cells of ependymoma, Cancer Cell, vol.8, issue.4, pp.323-335, 2005. ,
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice, Nature, vol.445, issue.7123, pp.106-110, 2007. ,
Molecular and cellular key players in human islet transplantation, Journal of Cellular and Molecular Medicine, vol.11, issue.3, pp.398-415, 2007. ,
Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics, Proceedings of the National Academy of Sciences of the United States of America, vol.105, pp.12469-12473, 2008. ,
Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells, Biochemical and Biophysical Research Communications, vol.351, issue.4, pp.820-824, 2006. ,
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells, Oncogene, vol.25, issue.12, pp.1696-1708, 2006. ,
Identification and expansion of the tumorigenic lung cancer stem cell population, Cell Death and Differentiation, vol.15, issue.3, pp.504-514, 2008. ,
Identification of cells initiating human melanomas, Nature, vol.451, issue.7176, pp.345-349, 2008. ,
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions, Nature Reviews Cancer, vol.8, issue.10, pp.755-768, 2008. ,
Modeling the initiation and progression of human acute leukemia in mice, Science, vol.316, issue.5824, pp.600-604, 2007. ,
Genomic analysis of metastasis reveals an essential role for RhoC, Nature, vol.406, issue.6795, pp.532-535, 2000. ,
On the stem cell origin of cancer, American Journal of Pathology, vol.176, issue.6, pp.2584-2494, 2010. ,
Human breast epithelial stem cells and their regulation, Journal of Pathology, vol.208, issue.1, pp.7-16, 2006. ,
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma, Cancer Research, vol.64, issue.19, pp.7011-7021, 2004. ,
CREB is a critical regulator of normal hematopoiesis and leukemogenesis, Blood, vol.111, issue.3, pp.1182-1192, 2008. ,
mTOR signal and hypoxia-inducible factor-1 regulate CD133 expression in cancer cells, Cancer Research, vol.69, pp.7160-7164, 2009. ,
CD133 is a marker of bioenergetic stress in human glioma, PLoS ONE, vol.3, issue.11, 2008. ,
Expression of the class VI intermediate filament nestin in human central nervous system tumors, Cancer Research, vol.52, issue.19, pp.5334-5341, 1992. ,
SSEA-1 Is an enrichment marker for tumor-initiating cells in human glioblastoma, Cell Stem Cell, vol.4, issue.5, pp.440-452, 2009. ,
HIF1 induced switch from bivalent to exclusively glycolytic metabolism during ESCto-EpiSC/hESC transition, The EMBO Journal, vol.31, pp.2103-2116, 2012. ,
Early human embryo metabolism, BioEssays, vol.15, issue.4, pp.259-264, 1993. ,
Changes in the metabolism of glucose, pyruvate, glutamine and glycine during maturation of cattle oocytes in vitro, Journal of Reproduction and Fertility, vol.100, issue.1, pp.257-262, 1994. ,
Energy metabolism in human pluripotent stem cells and their differentiated counterparts, PLoS ONE, vol.6, issue.6, 2011. ,
Comparison of spheroids formed by rat glioma stem cells and neural stem cells reveals differences in glucose metabolism and promising therapeutic applications, Journal of Biological Chemistry, vol.287, pp.33664-33674, 2012. ,
Glycolysis, respiration, and anomalous gene expression in experimental hepatomas: G.H.A. Clowes memorial lecture, Cancer Research, vol.32, issue.10, pp.2007-2016, 1972. ,
Metabolic state of glioma stem cells and nontumorigenic cells, Proceedings of the National Academy of Sciences of the United States of America, vol.108, issue.38, pp.16062-16067, 2011. ,
Glycine decarboxylase activity drives non-small cell Lung cancer tumorinitiating cells and tumorigenesis, Cell, vol.148, issue.1, pp.259-272, 2012. ,
Molecular insights into the function, fate, and prospects of stem cells, Stem Cells, vol.23, issue.8, pp.1212-1220, 2005. ,
More than structural cells, fibroblasts create and orchestrate the tumor microenvironment, Immunological Investigations, vol.35, issue.3-4, pp.297-325, 2006. ,
Stem cells and their niches, Science, vol.311, issue.5769, pp.1880-1885, 2006. ,
Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment?, Cancer Cell, vol.7, issue.1, pp.17-23, 2005. ,
Normal stem cells and cancer stem cells: the niche matters, Cancer Research, vol.66, issue.9, pp.4553-4557, 2006. ,
Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy, Current Molecular Pharmacology, vol.2, issue.3, pp.263-284, 2009. ,
A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2, Brain, vol.133, issue.4, pp.983-995, 2010. ,
Notch signaling enhances nestin expression in gliomas, Neoplasia, vol.8, issue.12, pp.1072-1082, 2006. ,
Acidic stress promotes a glioma stem cell phenotype, Cell Death and Differentiation, vol.18, issue.5, pp.829-840, 2011. ,
Hypoxia inducible factors in cancer stem cells, British Journal of Cancer, vol.102, issue.5, pp.789-795, 2010. ,
Lysyl oxidase is essential for hypoxia-induced metastasis, Nature, vol.440, issue.7088, pp.1222-1226, 2006. ,
Hypoxia and cancer, Journal of Molecular Medicine, vol.85, issue.12, pp.1301-1307, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00319797
Cancer stem cells, hypoxia and metastasis, Seminars in Radiation Oncology, vol.19, issue.2, pp.106-111, 2009. ,
Hallmarks of cancer: the next generation, Cell, vol.144, issue.5, pp.646-674, 2011. ,
Bax activation and mitochondrial insertion during apoptosis, Apoptosis, vol.12, issue.5, pp.887-896, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00131560
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma, Molecular Cancer, vol.5, p.67, 2006. ,
Metabolic regulation of protein N-alpha-acetylation by Bcl-xL promotes cell survival, Cell, vol.146, issue.4, pp.607-620, 2011. ,
Targeting death and decoy receptors of the tumour-necrosis factor superfamily, International Journal of Cell Biology, vol.2, issue.6, pp.420-430, 2002. ,
Promoting apoptosis as a strategy for cancer drug discovery, Nature Reviews Cancer, vol.5, issue.11, pp.876-885, 2005. ,
Bortezomib and TRAIL: a perfect match for apoptotic elimination of tumour cells?, Critical Reviews in Oncology, 2012. ,
TRAIL treatment provokes mutations in surviving cells, Oncogene, vol.29, issue.36, pp.5048-5060, 2010. ,
The role of apoptosis in the regulation of hematopoietic stem cells: overexpression of BCL-2 increases both their number and repopulation potential, Journal of Experimental Medicine, vol.191, issue.2, pp.253-263, 2000. ,
Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation, Blood, vol.91, issue.7, pp.2272-2282, 1998. ,
Bax limits adult neural stem cell persistence through caspase and IP3 receptor activation, Cell Death and Differentiation, vol.12, issue.12, pp.1601-1612, 2005. ,
Apoptosisbased treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins, Oncogene, vol.27, issue.52, pp.6646-6656, 2008. ,
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature, vol.444, issue.7120, pp.756-760, 2006. ,
Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme [1], Journal of Neuro-Oncology, vol.83, issue.1, pp.91-93, 2007. ,
Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells1 2, Neoplasia, vol.11, issue.4, pp.397-407, 2009. ,
Molecular characterization of spontaneous mesenchymal stem cell transformation, PLoS ONE, vol.3, issue.1, 2008. ,
Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells, Nature, vol.457, issue.7225, pp.51-56, 2009. ,
Distinct roles of bcl-2 and bcl-xl in the apoptosis of human bone marrow mesenchymal stem cells during differentiation, PLoS ONE, vol.6, issue.5, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01968410
Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation, Acta neuropathologica, vol.117, issue.4, pp.445-456, 2009. ,
Proteasome inhibitors sensitize glioma cells and glioma stem cells to TRAIL-induced apoptosis by PKC -dependent downregulation of AKT and XIAP expressions, Cellular Signalling, vol.23, issue.8, pp.1348-1357, 2011. ,
Cisplatin and TRAIL enhance breast cancer stem cell death, International Journal of Oncology, vol.39, issue.4, pp.891-898, 2011. ,
Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4, Cancer Biology and Therapy, vol.6, issue.9, pp.1490-1495, 2007. ,
WNT/ -catenin mediates radiation resistance of mouse mammary progenitor cells, Proceedings of the National Academy of Sciences of the United States of America, vol.104, issue.2, pp.618-623, 2007. ,
A role for GAPDH in apoptosis and neurodegeneration, Nature Medicine, vol.2, pp.609-610, 1996. ,
Cells overexpressing fructose-2,6-bisphosphatase showed enhanced pentose phosphate pathway flux and resistance to oxidative stress, FEBS Letters, vol.480, issue.2-3, pp.261-264, 2000. ,
Glucose withdrawal induces oxidative stress followed by apoptosis in glioblastoma cells but not in normal human astrocytes, Molecular Cancer Research, vol.4, issue.5, pp.319-330, 2006. ,
Glucose deprivation induces an atypical form of apoptosis mediated by caspase-8 in Bax-, Bak-deficient cells, Cell Death and Differentiation, vol.17, issue.8, pp.1335-1344, 2010. ,
Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions, Cancer Chemotherapy and Pharmacology, vol.53, issue.2, pp.116-122, 2004. ,
Optimizing cancer radiotherapy with 2-deoxy-D-glucose: dose escalation studies in patients with glioblastoma multiforme, Strahlentherapie und Onkologie, vol.181, pp.507-514, 2005. ,
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth, Cancer Cell, vol.11, issue.1, pp.37-51, 2007. ,
Dichloroacetate (DCA) sensitizes both wild-type and over expressing bcl-2 prostate cancer cells in vitro to radiation, Prostate, vol.68, issue.11, pp.1223-1231, 2008. ,
Dichloroacetate induces apoptosis in endometrial cancer cells, Gynecologic Oncology, vol.109, issue.3, pp.394-402, 2008. ,
Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo, Breast Cancer Research and Treatment, vol.120, issue.1, pp.253-260, 2010. ,
Role of dichloroacetate in the treatment of genetic mitochondrial diseases, Advanced Drug Delivery Reviews, vol.60, pp.1478-1487, 2008. ,
Metabolic modulation of glioblastoma with dichloroacetate, Science Translational Medicine, vol.2, issue.31, pp.31-34, 2010. ,
TIGAR, a p53-inducible regulator of glycolysis and apoptosis, Cell, vol.126, issue.1, pp.107-120, 2006. ,
p53 and metabolism: inside the TIGAR, Cell, vol.126, issue.1, pp.30-32, 2006. ,
Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death, Cancer Research, vol.67, issue.4, pp.1602-1608, 2007. ,
Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply, Experimental Cell Research, vol.315, issue.16, pp.2765-2774, 2009. ,
Evaluation of substituted N,N -diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase, Journal of Medicinal Chemistry, vol.53, issue.3, pp.1048-1055, 2010. ,
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells, Nature, vol.444, issue.7120, pp.761-765, 2006. ,